Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Blood|June 27, 2009
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)Ivan M Borrello, Hyam I Levitsky, Wendy Stock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusionWandi Zhang, Jaewon Choi, Wanyong Zeng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2011
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303Steven M Devine, Shelly Carter, Robert J Soiffer, et al.
Blood|April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationVincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host diseaseSarah Nikiforow, Haesook T Kim, Bhavjot Bindra, et al.
Blood|March 6, 2016
Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseEdouard Forcade, Haesook T Kim, Corey Cutler, et al.
Blood|November 1, 2008
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantationAsad Bashey, Bridget Medina, Sue Corringham, et al.
Blood|January 27, 2009
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host diseaseStefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipientsNicolas C Issa, Francisco M Marty, Lisa S Gagne, et al.
Blood|April 19, 2014
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationPhilippe Armand, Haesook T Kim, Brent R Logan, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Blood|June 27, 2009
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)Ivan M Borrello, Hyam I Levitsky, Wendy Stock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusionWandi Zhang, Jaewon Choi, Wanyong Zeng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2011
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303Steven M Devine, Shelly Carter, Robert J Soiffer, et al.
Blood|April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationVincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host diseaseSarah Nikiforow, Haesook T Kim, Bhavjot Bindra, et al.
Blood|March 6, 2016
Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseEdouard Forcade, Haesook T Kim, Corey Cutler, et al.
Blood|November 1, 2008
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantationAsad Bashey, Bridget Medina, Sue Corringham, et al.
Blood|January 27, 2009
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host diseaseStefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipientsNicolas C Issa, Francisco M Marty, Lisa S Gagne, et al.
Blood|April 19, 2014
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationPhilippe Armand, Haesook T Kim, Brent R Logan, et al.
Pageof 18